Sign in
4

Changes in Ownership

REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-24-000132

EVP Commercial sold 1,000 shares at $844.61 ($844,610)

  • EVP Commercial acquired 1,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

McCourt Marion · EVP Commercial

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-11-01 Exercise or conversion : show line 1 in the form 10b5-1 +1,000 $381.40 $381,400 13,931 D
2024-11-01 Sale : show line 2 in the form 10b5-1 −1,000 $844.61 $844,610 12,931 D
Open-market sales · 1,000 sh · avg $844.61 · $844,610

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-11-01 Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) −1,000 6,000 D
Loading xslF345X05/edgardoc.xml…